Earnings History Data for Mineralys Therapeutics, Inc. (MLYS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Mineralys Therapeutics, Inc.
Mineralys Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics Inc. is based in RADNOR, Pa.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11-11-2024 | AH | MLYS | Mineralys Therapeutics, Inc. | 704.13 | -1.13 | -0.83 | -0.57 | Mineralys Therapeutics GAAP EPS of -$1.13 misses by $0.31 [11/11/2024 4:16 PM] |
13.35 | -1.57 (-10.56%) |
14.61 | -0.31 (-2.08%) |
5.85 - 16.91 | 345,929 | 310,000 | 363 | ||
| 13-08-2024 | AH | MLYS | Mineralys Therapeutics, Inc. | 555.00 | -0.83 | -0.73 | 0.00 | Mineralys Therapeutics GAAP EPS of -$0.83 misses by $0.12 [8/13/2024 4:25 PM] |
9.17 | -2.66 (-22.49%) |
11.83 | 0.0 (0.00%) |
5.85 - 16.91 | 637,194 | 140,000 | 1,647 | ||
| 09-05-2024 | PM | MLYS | Mineralys Therapeutics, Inc. | 703.27 | -0.70 | -0.68 | -0.51 | Mineralys Therapeutics GAAP EPS of -$0.70 misses by $0.03 [5/9/2024 7:38 AM] |
14.21 | -0.44 (-3.00%) |
0.0 | 0.0 (0.00%) |
5.85 - 17.70 | 165,879 | 210,000 | 0 | ||
| 21-03-2024 | PM | MLYS | Mineralys Therapeutics, Inc. | 518.34 | -0.61 | -0.85 | -1.74 | Mineralys Therapeutics GAAP EPS of -$0.61 beats by $0.21 [3/21/2024 7:19 AM] |
12.84 | -0.55 (-4.11%) |
0.0 | 0.0 (0.00%) |
5.85 - 17.70 | 386,560 | 150,000 | 0 | ||
| 07-11-2023 | AH | MLYS | Mineralys Therapeutics, Inc. | 339.52 | -0.57 | -0.72 | 0.00 | Mineralys Therapeutics GAAP EPS of -$0.57 [11/7/2023 4:57 PM] |
8.22 | -0.53 (-6.06%) |
8.75 | 0.0 (0.00%) |
7.44 - 21.98 | 213,930 | 270,000 | 2,943 | ||
| 07-08-2023 | AH | MLYS | Mineralys Therapeutics, Inc. | 557.28 | -0.31 | -0.83 | 0.00 | Mineralys Therapeutics GAAP EPS of -$0.31 beats by $0.45 [8/7/2023 5:51 PM] |
13.35 | 0.85 (6.80%) |
12.50 | 0.0 (0.00%) |
12.01 - 21.98 | 172,459 | 90,000 | 1,185 | ||
| 15-05-2023 | AH | After the close (May 15) |
MLYS | Mineralys Therapeutics, Inc. | 655.34 | -0.51 | -0.71 | 0.00 | Mineralys Therapeutics Inc GAAP EPS of -$0.51 beats by $0.33 [5/15/2023 4:12 PM] |
15.44 | -0.75 (-4.63%) |
16.19 | 0.0 (0.00%) |
12.62 - 21.98 | 54,915 | 110,000 | 433 | |
| 15-03-2023 | AH | After the close (Mar 15) |
MLYS | Mineralys Therapeutics, Inc. | 703.02 | -1.74 | 0.00 | 0.00 | GAAP EPS of -$1.74 misses by $0.02 [3/15/2023 5:09 PM] |
15.37 | -0.98 (-5.99%) |
0.0 | 0.0 (0.00%) |
15.04 - 21.98 | 361,402 | 240,000 | 0 | |